Bachem Holding AG (XSWX:BANB) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:BANB Bachem Holding AG XSWX:BANB
97 GF Score
Price CHF74.40
GF Value CHF97.60
Valuation Modestly Undervalued
! 7 Warning Signs
View Full Analysis

What is Bachem Holding AG FFO per Share?

FFO per Share only applies to REITs.

XSWX:BANB
97GF Score
Bachem Holding AG XSWX:BANB
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bachem Holding AG (XSWX:BANB) Overvalued in 2026?

Based on GuruFocus' analysis, Bachem Holding AG stock appears to be undervalued. The current stock price of CHF74.40 is trading 23.8% below its estimated GF Value™ of CHF97.60. GuruFocus considers Bachem Holding AG to be Modestly Undervalued.

Key valuation signals for XSWX:BANB:

  • FFO per Share:
  • GF Value™: CHF97.60 vs. price of CHF74.40 (23.8% below fair value)
  • GF Score™: 97/100 with 7 warning signs

No single metric tells the full story. See the XSWX:BANB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bachem Holding AG Business Description

Address Hauptstrasse 144, Bubendorf, CHE, 4416
Bachem Holding AG is a biochemical company that provides services to the pharmaceutical and biotechnology industry. It focuses on specializing in the development and manufacture of peptides and oligonucleotides. The group markets its products under the Bachem and Clinalfa brands. Its products and services are CMC Development, Commercial API, Research and Specialities, and Services and Capabilities. Geographically, it operates in Switzerland, USA, Ireland, Denmark, United Kingdom, and Rest of the World.
97GF Score

Get the complete analysis for XSWX:BANB

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF74.40
Price
CHF97.60
GF Value